K. Sivagourounadin, V. Subbiah, G. Krishnasamy, and P. Rajendran, “A study on haloperidol and risperidone induced metabolic derangements in patients with newly diagnosed schizophrenia”, Int J Basic Clin Pharmacol, vol. 9, no. 2, pp. 282–288, Jan. 2020.